These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22455591)

  • 1. Supramolecular approaches for drug development.
    Kawakami K; Ebara M; Izawa H; Sanchez-Ballester NM; Hill JP; Ariga K
    Curr Med Chem; 2012; 19(15):2388-98. PubMed ID: 22455591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Trends in Clinical Trials Related to Carrier-Based Drugs.
    Tagami T; Ozeki T
    J Pharm Sci; 2017 Sep; 106(9):2219-2226. PubMed ID: 28259767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of liposomal and microemulsion formulations for transdermal delivery of clonazepam: effect of randomly methylated β-cyclodextrin.
    Mura P; Bragagni M; Mennini N; Cirri M; Maestrelli F
    Int J Pharm; 2014 Nov; 475(1-2):306-14. PubMed ID: 25194352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pH-sensitive supramolecular assemblies for oral delivery of poorly water soluble drugs: preparation and characterization.
    Sant VP; Smith D; Leroux JC
    J Control Release; 2004 Jun; 97(2):301-12. PubMed ID: 15196757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
    Narang AS; Chang RK; Hussain MA
    J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs.
    He CX; He ZG; Gao JQ
    Expert Opin Drug Deliv; 2010 Apr; 7(4):445-60. PubMed ID: 20201713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery systems for biopharmaceuticals. Part II: Liposomes, Micelles, Microemulsions and Dendrimers.
    Silva AC; Lopes CM; Lobo JM; Amaral MH
    Curr Pharm Biotechnol; 2015; 16(11):955-65. PubMed ID: 26278524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Design of Layer-by-Layer Functionalized Liposomes for Oral Drug Delivery.
    Lai WF; Wong WT; Rogach AL
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43341-43351. PubMed ID: 32877163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery systems for cyclosporine: achievements and complications.
    Klyashchitsky BA; Owen AJ
    J Drug Target; 1998; 5(6):443-58. PubMed ID: 9783676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of microemulsion based drug delivery system.
    Jadhav KR; Shaikh IM; Ambade KW; Kadam VJ
    Curr Drug Deliv; 2006 Jul; 3(3):267-73. PubMed ID: 16848728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art.
    Moutinho CG; Matos CM; Teixeira JA; Balcão VM
    J Drug Target; 2012 Feb; 20(2):114-41. PubMed ID: 22023555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microemulsion and mixed micelle for oral administration as new drug formulations for highly hydrophilic drugs.
    Mrestani Y; Behbood L; Härtl A; Neubert RH
    Eur J Pharm Biopharm; 2010 Feb; 74(2):219-22. PubMed ID: 19932178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colloidal soft matter as drug delivery system.
    Bonacucina G; Cespi M; Misici-Falzi M; Palmieri GF
    J Pharm Sci; 2009 Jan; 98(1):1-42. PubMed ID: 18452176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs.
    Kotta S; Khan AW; Pramod K; Ansari SH; Sharma RK; Ali J
    Expert Opin Drug Deliv; 2012 May; 9(5):585-98. PubMed ID: 22512597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs.
    Kayser O; Olbrich C; Croft SL; Kiderlen AF
    Parasitol Res; 2003 Jun; 90 Suppl 2():S63-70. PubMed ID: 12937968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro-in vivo evaluation.
    Soliman OAE; Mohamed EA; Khatera NAA
    Pharm Dev Technol; 2019 Jan; 24(1):48-62. PubMed ID: 29210317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developments of Polysorbate (Tween) based microemulsions: Preclinical drug delivery, toxicity and antimicrobial applications.
    Kaur G; Mehta SK
    Int J Pharm; 2017 Aug; 529(1-2):134-160. PubMed ID: 28642203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microemulsions as carriers for drugs and nutraceuticals.
    Spernath A; Aserin A
    Adv Colloid Interface Sci; 2006 Dec; 128-130():47-64. PubMed ID: 17229398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable drug encapsulation in micelles and microemulsions.
    Narang AS; Delmarre D; Gao D
    Int J Pharm; 2007 Dec; 345(1-2):9-25. PubMed ID: 17945446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of colloidal soft nano-carriers for transdermal delivery and bioavailability enhancement of an angiotensin II receptor blocker.
    Hathout RM; Elshafeey AH
    Eur J Pharm Biopharm; 2012 Oct; 82(2):230-40. PubMed ID: 22820090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.